J. Russell Hoverman, MD, PhD

Research Reports

Treatment Pathways for First-Line Metastatic Non-Small Cell Lung Cancer: Cost and Survival

10/21/2020

Aimee Ginsburg , PharmD, BCPS;

J. Russell Hoverman , MD, PhD;

Angela Hsieh , PharmD, BCOP;

Kartik Konduri , MD;

Leslie T. Busby , MD;

Lalan Wilfong , MD;

John M. Burke , MD;

Marcus A. Neubauer , MD;

Abstract: Value Pathways powered by NCCN™ provides oncologists with a list of clinically proven treatment options that support the delivery of high-quality, cost-effective cancer care. We evaluated the economic and...

...

10/21/2020

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 13 ⁠–⁠ November 16

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

See Full Calendar

J. Russell Hoverman, MD, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products